Statin Use in Patients With Chronic Liver Disease and Cirrhosis: Current Evidence and Future Directions

Chronic liver disease (CLD) and its complications constitute a significant cause of mortality and morbidity worldwide. Most deaths are secondary to the decompensation of cirrhosis and evolution of portal hypertension (PHTN). Since disease progression reversal is hardly attainable after decompensated...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreidieh, Malek, Hamadi, Rachelle, Alsheikh, Mira, Al Moussawi, Hassan, Deeb, Liliane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913022/
https://www.ncbi.nlm.nih.gov/pubmed/35369681
http://dx.doi.org/10.14740/gr1498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913022/
https://www.ncbi.nlm.nih.gov/pubmed/35369681
http://dx.doi.org/10.14740/gr1498

Ejemplares similares